Latest News

Epilepsy community seeks redefinition of bioequivalence from FDA

For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration?s (FDA) definition of bioequivalence as it applies to narrow therapeutic index (NTI) drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Scientists discover molecular link between psychiatric disorders and type 2 diabetes

  • Head injury patients develop brain clumps associated with Alzheimer?s disease

  • Neurobiological changes explain how mindfulness meditation improves health

  • Athlete passion linked to acceptance of performance enhancing drugs

  • Mesh-like scaffold is disordered in Alzheimer's-affected cells

  • Gambling is associated with 'risk-taking behavior' in young teens, study finds

  • Researchers home in on why female newborns are better protected from brain injury

  • Better quality of care may reduce risk of death for patients on opioid painkillers

  • First-of-its-kind study explains why rest is critical after a concussion

  • Aggression causes new nerve cells to be generated in the brain

  •